Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was reported, with innovations spanning targets, ...
Cidara Therapeutics skyrockets 1,165% after positive CD388 data and Merck's acquisition bid. Read why CDTX stock is a Hold.
A Jacksonville anesthesiologist and health care advocate urges residents to speak out against Florida's proposed rollback of ...
It was huge. Its light brown shell stood taller than the tip of my shoe. Its yellowish-green body stretched about an inch ...
BioAtla will receive an initial $5 million for general operating and Phase 3 clinical trial expenses to advance Oz-V in 2L+ OPSCC with the ...
A House Republican has filed a bill that says health-care providers could not “discriminate” against patients based on ...
Calling it the “Health Care Medical Freedom Act,” a House Republican on Monday filed a bill that says health-care providers ...
CX-5461 is the first G-quadruplex (G4) stabilizer in development. It has shown promising activity in early-phase trials for ...
Like other unserious candidates, Joe Oltmann’s presence further diminishes the state GOP at a time when the party is most ...
Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...
The Washington Examiner's Sarah Bedford said Rosie O’Donnell is partaking in the “outrage machine” against President Donald ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback